4//SEC Filing
BRADLEY PHARMACEUTICALS INC 4
Accession 0000864268-04-000009
CIK 0000864268operating
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 2:56 PM ET
Size
8.8 KB
Accession
0000864268-04-000009
Insider Transaction Report
Form 4
LENCZYCKI R BRENT
VP - CFO
Transactions
- Award
Common Stock
2004-01-07$23.88/sh+838$20,011→ 9,444 total
Holdings
- 6,000
Stock Options (Right to buy)
Exercise: $2.19From: 2001-03-13Exp: 2008-03-12→ Common Stock (6,000 underlying) - 60,000
Stock Options (Right to buy)
Exercise: $7.05From: 2004-07-09Exp: 2011-07-08→ Common Stock (60,000 underlying) - 3,152
Stock Options (Right to buy)
Exercise: $8.81From: 2003-07-09Exp: 2004-07-08→ Common Stock (3,152 underlying) - 1,265
Stock Options (Right to buy)
Exercise: $10.58From: 2003-07-09Exp: 2006-07-08→ Common Stock (1,265 underlying) - 2,170(indirect: By 401(k))
Common Stock
- 15,000
Stock Options (Right to buy)
Exercise: $2.00From: 2004-03-30Exp: 2011-03-29→ Common Stock (15,000 underlying) - 2,864(indirect: By 401(k))
Common Stock
Documents
Issuer
BRADLEY PHARMACEUTICALS INC
CIK 0000864268
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000864268
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 2:56 PM ET
- Size
- 8.8 KB